E-ISSN: 1309-0380
Implications of varied patterns of cervical cancer screening for introduction of human papillomavirus vaccines in Europe
PDF
Cite
Share
Request
Original Investigation
VOLUME: 10 ISSUE: 2
P: 61-67
June 2009

Implications of varied patterns of cervical cancer screening for introduction of human papillomavirus vaccines in Europe

J Turk Ger Gynecol Assoc 2009;10(2):61-67
Achim Schneider 1
Olivier Gleizes 2
Pekka Nieminen 3
Evrim Erdemoglu 1
Fausto Boselli 4
David Jenkins 5
1. Department Of Gynecology, Campus Benjamin Franklin And Campus Mitte, Charité University, Berlin, Germany
2. Smart Pharma Consulting, Paris, France
3. Department Of Obstetrics And Gynecology, Jorvi Hospital, Helsinski University, Helsinski, Finland
4. Department Of Obstetrics And Gynaecology, University Of Modena And Reggio Emilia, Modena, Italy
5. Glaxosmithkline Biologicals, Rixensart, Belgium
No information available.
No information available
Received Date: 13.01.2009
Accepted Date: 22.03.2009
PDF
Cite
Share
Request

ABSTRACT

CONCLUSION:

There are several different patterns of current cervical cancer secondary prevention in Europe. Implementation of vaccination against the major oncogenic HPV types 16/18 provides a potentially important tool to supplement these cervical screening and achieve optimal cervical cancer prevention. The challenges are different in each country cluster.

RESULTS:

A wide range of variation was found in structure, process and outcomes for cervical cancer screening programmes in Europe, but countries could be clustered on the basis of screening practice and outcomes. There was a relation between the quality of cervical cancer prevention programmes and the continuing cervical cancer burden.

METHODS:

A three-phase approach was designed to evalu¬ate pro¬grammes in different countries and to identify drivers and barriers to vac¬cine introduction. Countries were clustered according to their structure, pro¬cess, and outcomes of current secondary prevention programmes for cervical cancer. Main outcome measures: Detailed description of cervical cancer secondary prevention programmes (or¬gani¬sation, target population, screening algorithms, financing) was compared. Outcome based criteria were incidence rate, mortality rate, and coverage rate of women (proportion of women actually screened).

OBJECTIVE:

To identify patterns of variation in cervical cancer screening programmes in Europe to support planning public health human papillomavirus (HPV) vaccination strategies in cervical cancer prevention.

Keywords:
servikal kanser, tarama programi, Avrupa, asilama